Artelo Biosciences
(NASDAQ) ARTL
Artelo Biosciences Financials at a Glance
Market Cap
$5.37M
Revenue (TTM)
$0.00
Net Income (TTM)
$12.88M
EPS (TTM)
$-47.93
P/E Ratio
-0.16
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$8.04
Volume
828,346
Open
$7.20
Price
$8.04
Volume
828,346
Open
$7.20
Previous Close
$7.84
Daily Range
$7.20 - $9.39
52-Week Range
$2.96 - $85.80
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$8.04
Volume
828,346
Open
$7.20
Previous Close
$7.84
Daily Range
$7.20 - $9.39
52-Week Range
$2.96 - $85.80
ARTL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Artelo Biosciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
7
CEO
Gregory D. Gorgas, MBA
Website
www.artelobio.comHeadquarters
Solana Beach, CA 92075, US
ARTL Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-1625%
Return on Capital
9%
Return on Assets
-5%
Earnings Yield
-6.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.37M
Shares Outstanding
708.30K
Volume
828.35K
Short Interest
0.00%
Avg. Volume
2.80M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$11.40M
EBITDA
$12.54M
Operating Cash Flow
$8.52M
Capital Expenditure
$0.00
Free Cash Flow
$8.52M
Cash & ST Invst.
$600.00K
Total Debt
$693.00K
Artelo Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$5.37M
N/A
Market Cap/Employee
$894.77K
N/A
Employees
6
N/A
Net Income
$4.17M
-10.3%
EBITDA
$3.79M
+0.6%
Quarterly Fundamentals
Net Cash
$93.00K
-104.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$29.00K
-58.0%
Short Term Debt
$664.00K
+1797.1%
Return on Assets
-4.60%
N/A
Return on Invested Capital
9.17%
N/A
Free Cash Flow
$4.25M
-65.6%
Operating Cash Flow
$4.25M
-65.6%